المؤلفون: Parvova, Iva, Delyiski, Tzvetomir, Peteva, Parvoleta, Petkova, Valentina, Irfan, Irfan, Yordanov, Emanuil, Hristov, Emil

المصدر: Pharmacia, 71, 1-11, (2024-11-29)

مصطلحات موضوعية: systemic vasculitis, anti-neutrophil cytoplasmic antibody (ANCA), ANCA-associated vasculitis (AAV), health-related quality of life, SF-36 version 2, rituximab (RTX)

Relation: https://doi.org/10.3897/pharmacia.71.e140507.figure4; https://doi.org/10.3897/pharmacia.71.e140507.figure7; https://doi.org/10.3897/pharmacia.71.e140507.figure1; https://doi.org/10.3897/pharmacia.71.e140507.figure2; https://doi.org/10.3897/pharmacia.71.e140507.figure8; https://doi.org/10.3897/pharmacia.71.e140507.figure5; https://doi.org/10.3897/pharmacia.71.e140507.figure6; https://doi.org/10.3897/pharmacia.71.e140507.figure9; https://doi.org/10.3897/pharmacia.71.e140507.figure10; https://doi.org/10.3897/pharmacia.71.e140507.figure3; https://doi.org/10.1002/art.1780330803; https://doi.org/10.1037/1040-3590.7.3.309; https://doi.org/10.1002/art.1780400222; https://doi.org/10.1002/art.37715; https://doi.org/10.1007/s40273-016-0389-9; https://doi.org/10.1002/art.11471; https://doi.org/10.1093/qjmed/hci015; https://doi.org/10.1136/ard.2008.101279; https://doi.org/10.1093/rheumatology/keh548; https://doi.org/10.3897/pharmacia.71.e125421; https://doi.org/10.3897/pharmacia.71.e127867; https://doi.org/10.1002/1529-0131(200104)44:4; https://doi.org/10.1136/ard.2009.122952; https://doi.org/10.1097/01.mlg.0000230440.83375.4b; https://doi.org/10.1002/acr.20471; https://doi.org/10.1136/annrheumdis-2016-209133; https://doi.org/10.3897/pharmacia.71.e140507; oai:zenodo.org:14252631

الاتاحة: https://doi.org/10.3897/pharmacia.71.e140507

المؤلفون: Rangelov, Antoan, Momekov, Georgi, Parvova, Iva, Hristov, Emil, Kadinov, Boris, Marinov, Lyubomir

المصدر: Pharmacia, 71, 1-7, (2024-11-13)

مصطلحات موضوعية: kinase inhibitors, adverse drug reactions, rheumatologic diseases, systematic review

Relation: https://doi.org/10.3897/pharmacia.71.e139358.figure5; https://doi.org/10.3897/pharmacia.71.e139358.figure1; https://doi.org/10.3897/pharmacia.71.e139358.figure2; https://doi.org/10.3897/pharmacia.71.e139358.figure3; https://doi.org/10.3897/pharmacia.71.e139358.figure4; https://doi.org/10.1093/ecco-jcc/jjaa017; https://doi.org/10.1007/s10067-019-04833-6; https://doi.org/10.1093/rheumatology/kez087; https://doi.org/10.1002/art.41655; https://doi.org/10.1002/acr.24010; https://doi.org/10.1080/14740338.2020.1774550; https://doi.org/10.1093/rheumatology/keab294; https://doi.org/10.1016/S0140-6736(18)31116-4; https://doi.org/10.1177/0363546513497567; https://doi.org/10.1007/s10067-018-4299-4; https://doi.org/10.1080/14737140.2018.1527688; https://doi.org/10.1093/rheumatology/keaa117; https://doi.org/10.1007/s40257-021-00602-x; https://doi.org/10.1111/jdv.14695; https://doi.org/10.1021/acs.chemrestox.9b00387; https://doi.org/10.1021/jm0608107; https://doi.org/10.1021/jm020427b; https://doi.org/10.1016/S0140-6736(18)32483-8; https://doi.org/10.1186/s12913-014-0579-0; https://doi.org/10.5070/D3263047978; https://doi.org/10.1053/j.gastro.2020.01.001; https://doi.org/10.35465/27.4.2019.pp3-17; https://doi.org/10.35465/28.1.2020.pp3-19; https://doi.org/10.3897/pharmacia.71.e124471; https://doi.org/10.1080/14740338.2020.1799975; https://doi.org/10.1007/s40264-018-0651-5; https://doi.org/10.1136/bmj.g7647; https://doi.org/10.3390/jcm10030509; https://doi.org/10.1007/s40264-020-00958-9; https://doi.org/10.1016/S0140-6736(18)32463-2; https://doi.org/10.1016/j.mayocp.2020.01.039; https://doi.org/10.1111/1756-185X.14217; https://doi.org/10.1136/annrheumdis-2021-220822; https://doi.org/10.1056/NEJMoa2109927; https://doi.org/10.1186/s40360-024-00741-x; https://doi.org/10.3897/pharmacia.71.e139358; oai:zenodo.org:14167870

الاتاحة: https://doi.org/10.3897/pharmacia.71.e139358

المؤلفون: Petrova, Lora, Andreevska, Kalina, Parvova, Iva, Petkova, Valentina

المصدر: Pharmacia, 71, 1-17, (2024-08-02)

مصطلحات موضوعية: GLP-1 receptor agonists, diabetes mellitus, efficacy, safety, systematic review

Relation: https://doi.org/10.3897/pharmacia.71.e132148.figure1; https://doi.org/10.3897/pharmacia.71.e132148.figure2; https://doi.org/10.3897/pharmacia.71.e132148.figure3; https://doi.org/10.2337/dc12-2006; https://doi.org/10.1016/S2213-8587(17)30092-X; https://doi.org/10.1111/dom.12540; https://doi.org/10.1016/S2213-8587(17)30085-2; https://doi.org/10.2337/dc19-0749; https://doi.org/10.1016/S0140-6736(10)60590-9; https://doi.org/10.1111/dom.13978; https://doi.org/10.1111/dme.12328; https://doi.org/10.2337/dc09-1914; https://doi.org/10.2337/diacare.27.11.2628; https://doi.org/10.1016/S0140-6736(12)61267-7; https://doi.org/10.1016/S0140-6736(09)60659-0; https://doi.org/10.1111/dom.13340; https://doi.org/10.1001/jama.2022.0078; https://doi.org/10.2337/diacare.28.5.1092; https://doi.org/10.1080/13102818.2015.1042912; https://doi.org/10.15406/aowmc.2014.01.00001; https://doi.org/10.1111/dom.12634; https://doi.org/10.2337/dc23-S009; https://doi.org/10.3389/fcdhc.2023.1293926; https://doi.org/10.1056/NEJMoa2107519; https://doi.org/10.1111/dom.12908; https://doi.org/10.1016/S0140-6736(08)61246-5; https://doi.org/10.2337/dc14-1625; https://doi.org/10.1016/S2213-8587(14)70174-3; https://doi.org/10.2337/ds16-0026; https://doi.org/10.7326/M14-2385; https://doi.org/10.1016/j.clinthera.2012.07.007; https://doi.org/10.1016/S2213-8587(22)00188-7; https://doi.org/10.1111/dom.14232; https://doi.org/10.1016/S2213-8587(19)30311-0; https://doi.org/10.1111/j.1463-1326.2010.01251.x; https://doi.org/10.1016/S2213-8587(18)30023-8; https://doi.org/10.1016/S0140-6736(21)01443-4; https://doi.org/10.1111/j.1464-5491.2009.02666.x; https://doi.org/10.1186/s12913-014-0579-0; https://doi.org/10.1371/journal.pmed.1000097; https://doi.org/10.1016/S2213-8587(19)30192-5; https://doi.org/10.2337/dc08-1355; https://doi.org/10.2337/dc13-2761; https://doi.org/10.3390/pharmacy6030057; https://doi.org/10.35465/27.4.2019.pp3-17; https://doi.org/10.3897/pharmacia.71.e124471; https://doi.org/10.3897/pharmacia.71.e120141; https://doi.org/10.5897/AJPP11.098; https://doi.org/10.2337/dc12-2454; https://doi.org/10.2337/dc19-0883; https://doi.org/10.2337/dc12-2709; https://doi.org/10.1016/S0140-6736(21)01324-6; https://doi.org/10.2337/dc11-1107; https://doi.org/10.1111/dom.13082; https://doi.org/10.1136/bmj.g7647; https://doi.org/10.1016/S2213-8587(17)30013-X; https://doi.org/10.1111/dom.14036; https://doi.org/10.2337/dc13-2759; https://doi.org/10.2337/dc13-2760; https://doi.org/10.1111/dom.13056; https://doi.org/10.1016/S2213-8587(20)30075-9; https://doi.org/10.3389/fendo.2021.721135; https://doi.org/10.2337/dc19-0898; https://doi.org/10.2337/dc08-2124; https://doi.org/10.3897/pharmacia.71.e132148; oai:zenodo.org:13208191

الاتاحة: https://doi.org/10.3897/pharmacia.71.e132148

المؤلفون: Cannavale, Carmen, De Rosa, Assunta, Yordanov, Emanuil, Parvova, Iva, Hristov, Emil, Petkova, Valentina

المصدر: Pharmacia, 71, 1-8, (2024-07-29)

مصطلحات موضوعية: pricing, reimbursement, cost sharing, comparative analysis, Italy, Bulgaria

Relation: https://doi.org/10.3897/pharmacia.71.e131159.figure1; https://doi.org/10.3897/pharmacia.71.e131159.figure2; https://doi.org/10.3897/pharmacia.71.e131159.figure3; https://doi.org/10.2427/5948; https://doi.org/10.1016/j.healthpol.2011.09.008; https://doi.org/10.1787/8d90f882-en; https://doi.org/10.1787/633496ec-en; https://doi.org/10.5655/smr.v4i2.1004; https://doi.org/10.3897/pharmacia.71.e131159; oai:zenodo.org:13140861

الاتاحة: https://doi.org/10.3897/pharmacia.71.e131159

المؤلفون: Dimitrov, Rumen, Haralanova, Evelina, Milanov, Ivan, Ognianov, Sava, Parvova, Iva, Milushev, Emil

المصدر: Pharmacia, 71, 1-6, (2024-06-20)

مصطلحات موضوعية: depression, pharmacological treatment, pharmacodynamic biomarkers, locomotor behavior, psychomotor retardation

Relation: https://doi.org/10.3897/pharmacia.71.e125942.figure3; https://doi.org/10.3897/pharmacia.71.e125942.figure1; https://doi.org/10.3897/pharmacia.71.e125942.figure2; https://doi.org/10.1016/S1353-8020(08)70331-6; https://doi.org/10.3389/fpsyt.2014.00196; https://doi.org/10.1016/j.psychres.2019.112687; https://doi.org/10.1155/2013/158746; https://doi.org/10.1016/j.jad.2012.07.001; https://doi.org/10.1016/j.pnpbp.2010.10.019; https://doi.org/10.1016/j.jad.2010.08.004; https://doi.org/10.3109/08039488.2014.936501; https://doi.org/10.1001/jama.2017.3826; https://doi.org/10.1007/978-3-030-61721-9_39; https://doi.org/10.1001/jamapsychiatry.2017.4602; https://doi.org/10.1023/B:JOBM.0000013642.43978.f9; https://doi.org/10.1016/S0022-3956(00)00017-0; https://doi.org/10.1016/j.jad.2012.08.043; https://doi.org/10.1097/01.wnf.0000240949.41691.95; https://doi.org/10.1016/0165-1781(94)90122-8; https://doi.org/10.1016/j.psychres.2011.05.028; https://doi.org/10.5114/ppn.2019.89129; https://doi.org/10.1016/0006-3223(94)91256-4; https://doi.org/10.1016/j.jad.2007.10.019; https://doi.org/10.1176/ajp.139.1.94; https://doi.org/10.1111/jep.12916; https://doi.org/10.3109/15622970701403081; https://doi.org/10.1055/s-2002-32025; https://doi.org/10.1016/S0193-953X(18)30838-4; https://doi.org/10.1038/s41380-023-02327-1; https://doi.org/10.3897/pharmacia.71.e125942; oai:zenodo.org:12228046

الاتاحة: https://doi.org/10.3897/pharmacia.71.e125942

المؤلفون: Parvova, Iva, Delyiski, Tzvetomir, Peteva, Parvoleta, Marinchev, Lubomir, Hristov, Emil, Yordanov, Emanuil, Petkova, Valentina

المصدر: Pharmacia, 71, 1-9, (2024-07-12)

مصطلحات موضوعية: Systemic vasculitis, ANCA, Microscopic polyangiitis, Wegener granulomatosis, Churg- Strauss syndrome

Relation: https://doi.org/10.1681/ASN.2010050477; https://doi.org/10.1002/art.1780330803; https://doi.org/10.1136/annrheumdis-2012-202111; https://doi.org/10.1093/rheumatology/ker205; https://doi.org/10.1097/MD.0b013e318205a4c6; https://doi.org/10.1097/00005792-199601000-00003; https://doi.org/10.1002/art.1780400222; https://doi.org/10.1111/j.1398-9995.2012.02873.x; https://doi.org/10.1016/0002-9343(79)90634-X; https://doi.org/10.7326/0003-4819-155-5-201109060-00026; https://doi.org/10.1093/rheumatology/kem107; https://doi.org/10.1136/ard.2008.101279; https://doi.org/10.1093/rheumatology/ket445; https://doi.org/10.1002/1529-0131(200104)44:4; https://doi.org/10.1093/rheumatology/ker454; https://doi.org/10.1136/annrheumdis-2016-209133; https://doi.org/10.3897/pharmacia.71.e125421; oai:zenodo.org:12738953

الاتاحة: https://doi.org/10.3897/pharmacia.71.e125421

المؤلفون: Parvova, Iva, Delyiski, Tzvetomir, Peteva, Parvoleta, Petkova, Valentina, Hristov, Еmil, Yordanov, Emanuil, Marinchev, Lubomir, Milushev, Emil, Dimitrov, Milen

المصدر: Pharmacia, 71, 1-9, (2024-06-20)

مصطلحات موضوعية: Systemic vasculitis, anti -neutrophil cytoplasmic antibody (ANCA), ANCA-associated vasculitis (AAV), EuroQol-5D-5 L, visual analog scale (VAS), rituximab (RTX)

Relation: https://doi.org/10.3897/pharmacia.71.e127867.figure1; https://doi.org/10.3897/pharmacia.71.e127867.figure2; https://doi.org/10.1097/MD.0b013e318205a4c6; https://doi.org/10.1136/annrheumdis-2012-202111; https://doi.org/10.1007/s10198-020-01225-5; https://doi.org/10.1002/art.37715; https://doi.org/10.1002/art.1780330802; https://doi.org/10.1093/qjmed/hci015; https://doi.org/10.1136/ard.2008.101279; https://doi.org/10.1002/1529-0131(200104)44:4; https://doi.org/10.1136/ard.2009.122952; https://doi.org/10.1136/annrheumdis-2016-209133; https://doi.org/10.3897/pharmacia.71.e127867; oai:zenodo.org:12228034

الاتاحة: https://doi.org/10.3897/pharmacia.71.e127867

المؤلفون: Parvova, Iva, Yordanov, Emanuil, Hristov, Emil, Petkova, Valentina

المصدر: Pharmacia, 71, 1-8, (2024-05-22)

مصطلحات موضوعية: biological medicinal products, tyrosine kinase inhibitors, COVID-19, rheumatologic diseases, systematic review

Relation: https://doi.org/10.3897/pharmacia.71.e124471.figure1; https://doi.org/10.1128/br.35.3.235-241.1971; https://doi.org/10.1038/s41392-020-0191-1; https://doi.org/10.1007/s00296-021-04969-2; https://doi.org/10.1177/1759720X20962692; https://doi.org/10.1016/S2665-9913(20)30169-7; https://doi.org/10.7326/M14-2385; https://doi.org/10.1177/0363546513497567; https://doi.org/10.1016/B978-0-323-09138-1.00251-5; https://doi.org/10.5114/aoms.2020.94503; https://doi.org/10.1016/j.metop.2021.100116; https://doi.org/10.1016/S0140-6736(20)30251-8; https://doi.org/10.1186/s12913-014-0579-0; https://doi.org/10.1016/j.semarthrit.2020.05.001; https://doi.org/10.1007/s00296-021-04818-2; https://doi.org/10.1371/journal.pmed.1000097; https://doi.org/10.1002/cbic.202000047; https://doi.org/10.1016/j.jbspin.2020.05.003; https://doi.org/10.2174/1381612827666210311141512; https://doi.org/10.1136/annrheumdis-2013-204575; https://doi.org/10.1136/rmdopen-2020-001439; https://doi.org/10.1136/annrheumdis-2016-210715; https://doi.org/10.1136/bmj.g7647; https://doi.org/10.1007/s11095-020-02851-7; https://doi.org/10.46497/ArchRheumatol.2021.8364; https://doi.org/10.3897/pharmacia.71.e124471; oai:zenodo.org:11274844

الاتاحة: https://doi.org/10.3897/pharmacia.71.e124471

المؤلفون: Nachev, Nikolay, Stoyanova, Stefka, Rangelov, Antoan, Yordanov, Emanuil, Hristov, Emil I, Parvova, Iva, Petkova, Valentina

المصدر: Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector ; volume 18, issue 2, page 88-98 ; ISSN 1741-1343 1741-7090

الاتاحة: https://doi.org/10.1177/17411343211055896
https://journals.sagepub.com/doi/pdf/10.1177/17411343211055896
https://journals.sagepub.com/doi/full-xml/10.1177/17411343211055896

المؤلفون: Yordanov, Emanuil, Parvova, Iva, Hristov, Emil, Petkova, Valentina

المصدر: Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector ; volume 18, issue 3, page 145-153 ; ISSN 1741-1343 1741-7090

الاتاحة: https://doi.org/10.1177/17411343221076371
https://journals.sagepub.com/doi/pdf/10.1177/17411343221076371
https://journals.sagepub.com/doi/full-xml/10.1177/17411343221076371

المؤلفون: Gruev, Ivan, Stoyanova, Sefka, Hristov, Emil, Yordanov, Emanuil, Parvova, Iva

المصدر: Journal of Hypertension ; volume 42, issue Suppl 1, page e259 ; ISSN 0263-6352 1473-5598

الاتاحة: http://dx.doi.org/10.1097/01.hjh.0001022156.13612.e8
https://journals.lww.com/10.1097/01.hjh.0001022156.13612.e8

المؤلفون: Stoyanova, Stefka, Yordanov, Emanuil, Hristov, Emil, Parvova, Iva, Tzachev, Hristo, Petkova, Valentina

المصدر: Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector ; volume 18, issue 1, page 42-50 ; ISSN 1741-1343 1741-7090

الاتاحة: https://doi.org/10.1177/17411343211017627
https://journals.sagepub.com/doi/pdf/10.1177/17411343211017627
https://journals.sagepub.com/doi/full-xml/10.1177/17411343211017627

المؤلفون: Parvova, Iva, Delyiski, Tzvetomir, Peteva, Parvoleta, Petkova, Valentina, Irfan, Irfan, Yordanov, Emanuil, Hristov, Emil

مصطلحات موضوعية: systemic vasculitis, anti-neutrophil cytoplasmic antibody (ANCA), ANCA-associated vasculitis (AAV), health-related quality of life, SF-36 version 2, rituximab (RTX)

Relation: https://doi.org/10.3897/pharmacia.71.e140507; https://zenodo.org/record/14252631; https://doi.org/10.3897/pharmacia.71.e140507.figure8; oai:zenodo.org:14252663

الاتاحة: https://doi.org/10.3897/pharmacia.71.e140507.figure8

المؤلفون: Parvova, Iva, Delyiski, Tzvetomir, Peteva, Parvoleta, Petkova, Valentina, Irfan, Irfan, Yordanov, Emanuil, Hristov, Emil

مصطلحات موضوعية: systemic vasculitis, anti-neutrophil cytoplasmic antibody (ANCA), ANCA-associated vasculitis (AAV), health-related quality of life, SF-36 version 2, rituximab (RTX)

Relation: https://doi.org/10.3897/pharmacia.71.e140507; https://zenodo.org/record/14252631; https://doi.org/10.3897/pharmacia.71.e140507.figure7; oai:zenodo.org:14252661

الاتاحة: https://doi.org/10.3897/pharmacia.71.e140507.figure7

المؤلفون: Parvova, Iva, Delyiski, Tzvetomir, Peteva, Parvoleta, Petkova, Valentina, Irfan, Irfan, Yordanov, Emanuil, Hristov, Emil

مصطلحات موضوعية: systemic vasculitis, anti-neutrophil cytoplasmic antibody (ANCA), ANCA-associated vasculitis (AAV), health-related quality of life, SF-36 version 2, rituximab (RTX)

Relation: https://doi.org/10.3897/pharmacia.71.e140507; https://zenodo.org/record/14252631; https://doi.org/10.3897/pharmacia.71.e140507.figure9; oai:zenodo.org:14252665

الاتاحة: https://doi.org/10.3897/pharmacia.71.e140507.figure9

المؤلفون: Parvova, Iva, Delyiski, Tzvetomir, Peteva, Parvoleta, Petkova, Valentina, Irfan, Irfan, Yordanov, Emanuil, Hristov, Emil

مصطلحات موضوعية: systemic vasculitis, anti-neutrophil cytoplasmic antibody (ANCA), ANCA-associated vasculitis (AAV), health-related quality of life, SF-36 version 2, rituximab (RTX)

Relation: https://doi.org/10.3897/pharmacia.71.e140507; https://zenodo.org/record/14252631; https://doi.org/10.3897/pharmacia.71.e140507.figure6; oai:zenodo.org:14252659

الاتاحة: https://doi.org/10.3897/pharmacia.71.e140507.figure6

المؤلفون: Parvova, Iva, Delyiski, Tzvetomir, Peteva, Parvoleta, Petkova, Valentina, Irfan, Irfan, Yordanov, Emanuil, Hristov, Emil

مصطلحات موضوعية: systemic vasculitis, anti-neutrophil cytoplasmic antibody (ANCA), ANCA-associated vasculitis (AAV), health-related quality of life, SF-36 version 2, rituximab (RTX)

Relation: https://doi.org/10.3897/pharmacia.71.e140507; https://zenodo.org/record/14252631; https://doi.org/10.3897/pharmacia.71.e140507.figure5; oai:zenodo.org:14252657

الاتاحة: https://doi.org/10.3897/pharmacia.71.e140507.figure5

المؤلفون: Parvova, Iva, Delyiski, Tzvetomir, Peteva, Parvoleta, Petkova, Valentina, Irfan, Irfan, Yordanov, Emanuil, Hristov, Emil

مصطلحات موضوعية: systemic vasculitis, anti-neutrophil cytoplasmic antibody (ANCA), ANCA-associated vasculitis (AAV), health-related quality of life, SF-36 version 2, rituximab (RTX)

Relation: https://doi.org/10.3897/pharmacia.71.e140507; https://zenodo.org/record/14252631; https://doi.org/10.3897/pharmacia.71.e140507.figure10; oai:zenodo.org:14252649

الاتاحة: https://doi.org/10.3897/pharmacia.71.e140507.figure10

المؤلفون: Parvova, Iva, Delyiski, Tzvetomir, Peteva, Parvoleta, Petkova, Valentina, Irfan, Irfan, Yordanov, Emanuil, Hristov, Emil

مصطلحات موضوعية: systemic vasculitis, anti-neutrophil cytoplasmic antibody (ANCA), ANCA-associated vasculitis (AAV), health-related quality of life, SF-36 version 2, rituximab (RTX)

Relation: https://doi.org/10.3897/pharmacia.71.e140507; https://zenodo.org/record/14252631; https://doi.org/10.3897/pharmacia.71.e140507.figure2; oai:zenodo.org:14252651

الاتاحة: https://doi.org/10.3897/pharmacia.71.e140507.figure2

المؤلفون: Parvova, Iva, Delyiski, Tzvetomir, Peteva, Parvoleta, Petkova, Valentina, Irfan, Irfan, Yordanov, Emanuil, Hristov, Emil

مصطلحات موضوعية: systemic vasculitis, anti-neutrophil cytoplasmic antibody (ANCA), ANCA-associated vasculitis (AAV), health-related quality of life, SF-36 version 2, rituximab (RTX)

Relation: https://doi.org/10.3897/pharmacia.71.e140507; https://zenodo.org/record/14252631; https://doi.org/10.3897/pharmacia.71.e140507.figure3; oai:zenodo.org:14252653

الاتاحة: https://doi.org/10.3897/pharmacia.71.e140507.figure3